Soleno Therapeutics Securities Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Soleno Therapeutics · DCCR (VYKAT XR) · New Filing
Last updated
Case overview
- Defendant company
- Soleno Therapeutics
- Product or service
- DCCR (VYKAT XR)
- Case status
- New Filing
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Availability is based on each listed participation option and its deadline.
Lead Plaintiff Application
Investors who purchased Soleno common stock between March 26, 2025 and November 4, 2025 and suffered losses.
Contact Hagens Berman regarding the lead-plaintiff application and provide information about losses or knowledge relevant to the investigation.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Soleno Therapeutics Securities Class Action
Barchart.com ·